Rona Therapeutics (Shanghai) Co.
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $68M
Investors
- 9
About Rona Therapeutics (Shanghai) Co.
, Ltd. is a pharmaceutical company that focuses on the development of modular and programmable nucleic acid drugs. It was recognized as the National High-tech Enterprise. The company cooperated with KeyMed Biosciences, Ennovabio, Sanofi, and other enterprises. Yibin Shi, the company's founder, graduated from Fudan University, used to serve as the head of new product strategy in the Asia-Pacific oncology field of Roche Pharmaceuticals and the consulting consultant at Zhisheng Consulting. The company is mainly engaged in the research and development of nucleic acid drugs. It has GAIA Hepatic Targeting platform, APOLLO Central Nervous Delivery platform, and Extrahepatic Systemic Drug Delivery platform. The main products are siRNA drugs for diseases such as metabolism, central nervous system, ophthalmology, and tumors. Including PCSK9 siRNA for hypercholesterolemia and APOC3 siRNA for mixed hyperlipidemia, which adopt a modular and programmable mode. The company generates revenue by providing nucleic acid drugs. The company will use the funds to advance its delivery and chemical modification platform technologies, expand its siRNA clinical pipeline in cardiovascular metabolism and weight loss, and enhance its production capacity.
Who invested in Rona Therapeutics (Shanghai) Co.
9 investors across 2 rounds
See all investors in Rona Therapeutics (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rona Therapeutics (Shanghai) Co.
Who invested in Rona Therapeutics (Shanghai) Co.?
Rona Therapeutics (Shanghai) Co. has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rona Therapeutics (Shanghai) Co. raised?
Rona Therapeutics (Shanghai) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rona Therapeutics (Shanghai) Co. last raise money?
Rona Therapeutics (Shanghai) Co.'s most recent round on record is a Series A, in Jul 2024.
What does Rona Therapeutics (Shanghai) Co. do?
Rona Therapeutics (Shanghai) Co. is a biotechnology company.
Where is Rona Therapeutics (Shanghai) Co. headquartered?
Rona Therapeutics (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Rona Therapeutics (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Rona Therapeutics (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rona Therapeutics (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.